Formulation and Development of Transferrin Targeted Solid Lipid Nanoparticles for Breast Cancer Therapy

Formulation and Development of Transferrin Targeted Solid Lipid Nanoparticles for Breast Cancer Therapy

Breast cancer is conventionally treated by surgery, chemotherapy and radiation therapy followed by post operational hormonal therapy. Tamoxifen citrate is a best option to treat breast cancer because its selective estrogen receptor modulation activity. Owing to its antiestrogenic action on breast as...

Full description

Bibliographic Details
Main Authors:	Geeta S. Bhagwat, Rajani B. Athawale, Rajeev P. Gude, Shadab Md, Nabil A. Alhakamy, Usama A. Fahmy, Prashant Kesharwani
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-11-01
Series:	Frontiers in Pharmacology
Subjects:	breast cancer solid lipid nanoparticles cancer targeted drug delivery tamoxifen
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2020.614290/full

Similar Items

Corrigendum: Formulation and development of transferrin targeted solid lipid nanoparticles for breast cancer therapy
by: Geeta S. Bhagwat, et al.
Published: (2023-01-01)

Solid Self-Nano Emulsifying Nanoplatform Loaded with Tamoxifen and Resveratrol for Treatment of Breast Cancer
by: Nupur Shrivastava, et al.
Published: (2022-07-01)

Effects of tamoxifen-loaded erythropoietin-coated nanostructured lipid carrier on breast cancer cells and rat mammary gland tumour
by: Beh, Chaw Yee
Published: (2019)

Overview of Solid Lipid Nanoparticles in Breast Cancer Therapy
by: Kyumin Mo, et al.
Published: (2023-07-01)

Recent Progress of RGD Modified Liposomes as Multistage Rocket Against Cancer
by: Afsana Sheikh, et al.
Published: (2022-01-01)

Application of Solid Lipid Nanoparticles to Improve the Efficiency of Anticancer Drugs
by: Laura Bayón-Cordero, et al.
Published: (2019-03-01)

Enhanced Dissolution Efficiency of Tamoxifen Combined with Methacrylate Copolymers in Amorphous Solid Dispersions
by: Dayanne T. C. da Silva, et al.
Published: (2020-11-01)

Fabrication, characterization and functionalization of single-walled carbon nanotube conjugated with tamoxifen and its anticancer potential against human breast cancer cells
by: Oskoueian, Arshin
Published: (2018)

Solid Lipid Nanoparticles: Multitasking Nano-Carriers for Cancer Treatment
by: Júlia German-Cortés, et al.
Published: (2023-03-01)

Novel Tamoxifen Nanoformulations for Improving Breast Cancer Treatment: Old Wine in New Bottles
by: Candace M. Day, et al.
Published: (2020-03-01)

Tamoxifen Effects on the lipid profile in premenopausal women with Breast cancer: A follow up study
by: Zainab A. M. Ali, et al.
Published: (2018-12-01)

Biochemical differences between nano- and normal formulation of tamoxifen and other natural bioactive materials ameliorate breast cancer in experimental rats
by: Afaf Ezzat, et al.
Published: (2021-04-01)

Development, characterization, cytotoxicity and antitumor effect of tamoxifen-loaded solid lipid nanoparticles
by: Abbasalipourkabirreh, Roghayeh
Published: (2010)

Exploring the Relationship Between Tamoxifen and Hereditary Angioedema
by: Ana Raquel Pinto, et al.
Published: (2024-01-01)

Breast Cancer Case using Tamoxifen during Pregnancy: A Case Report and Literature Review
by: Kamal Eldein H. Mohamed, et al.
Published: (2017-07-01)

Uterine Carcinosarcoma Associated with Tamoxifen Use in a Menopausal ‎Patient: A Case Report ‎
by: T Ashrafganjoei, et al.
Published: (2015-12-01)

Formulation, characterization, and cellular toxicity assessment of tamoxifen-loaded silk fibroin nanoparticles in breast cancer
by: Afrasim Moin, et al.
Published: (2021-01-01)

Formulation and characterization of solid lipid nanoparticles, nanostructured lipid carriers and nanoemulsion of lornoxicam for transdermal delivery
by: Gönüllü Ümit, et al.
Published: (2015-03-01)

Clinical factors of the risk of hyperplastic endometry processes on tamoxifen therapy with breast cancer: Retrospective population study
by: Ekaterina O. Golubenko, et al.
Published: (2023-05-01)

Tamoxifen use and risk of endometrial cancer in breast cancer patients: A systematic review and dose–response meta‐analysis
by: Matin Ghanavati, et al.
Published: (2023-04-01)

Mastoparan, a Peptide Toxin from Wasp Venom Conjugated Fluvastatin Nanocomplex for Suppression of Lung Cancer Cell Growth
by: Nabil A. Alhakamy, et al.
Published: (2021-12-01)

Transferrin-Bearing, Zein-Based Hybrid Lipid Nanoparticles for Drug and Gene Delivery to Prostate Cancer Cells
by: Khadeejah Maeyouf, et al.
Published: (2023-11-01)

Tacrolimus-Loaded Solid Lipid Nanoparticle Gel: Formulation Development and In Vitro Assessment for Topical Applications
by: Abdul Shakur Khan, et al.
Published: (2022-02-01)

QbD Enabled Azacitidine Loaded Liposomal Nanoformulation and Its In Vitro Evaluation
by: Prashant Kesharwani, et al.
Published: (2021-01-01)

Maslinic acid solid lipid nanoparticles as hydrophobic anticancer drug carriers: Formulation, in vitro activity and in vivo biodistribution
by: Aixa Aguilera-Garrido, et al.
Published: (2023-07-01)

Endocrine therapy for metastatic solid pseudopapillary neoplasm of the pancreas: A case report
by: Anna Kornietskaya, et al.
Published: (2022-09-01)

Apamin-Conjugated Alendronate Sodium Nanocomplex for Management of Pancreatic Cancer
by: Nabil A. Alhakamy, et al.
Published: (2021-07-01)

Resveratrol-Loaded TPGS-Resveratrol-Solid Lipid Nanoparticles for Multidrug-Resistant Therapy of Breast Cancer: In Vivo and In Vitro Study
by: Wenrui Wang, et al.
Published: (2021-12-01)

Central Composite Design for Formulation and Optimization of Solid Lipid Nanoparticles to Enhance Oral Bioavailability of Acyclovir
by: Haniza Hassan, et al.
Published: (2021-09-01)

Tamoxifen Citrate- loaded synthetic high-density lipoproteins: Assessment of cellular toxicity in breast cancer cells
by: Ameerah A. Radhi, et al.
Published: (2023-02-01)

Polycaprolactone nanofibers as an adjuvant strategy for Tamoxifen release and their cytotoxicity on breast cancer cells
by: Ana D. Pinzón-García, et al.
Published: (2021-10-01)

Tamoxifen Modulates the Immune Landscape of the Tumour Microenvironment: The Paired Siglec-5/14 Checkpoint in Anti-Tumour Immunity in an In Vitro Model of Breast Cancer
by: Przemyslaw Wielgat, et al.
Published: (2023-03-01)

Thymoquinone Could Increase The Efficacy of Tamoxifen Induced Apoptosis in Human Breast Cancer Cells: An In Vitro Study
by: Sedigheh Ganji-Harsini, et al.
Published: (2016-07-01)

DMH1 (4-[6-(4-isopropoxyphenyl)pyrazolo[1,5-a]pyrimidin-3-yl]quinoline) inhibits chemotherapeutic drug-induced autophagy
by: Yue Sheng, et al.
Published: (2015-07-01)

Exosome-Mediated Transfer of Cancer Cell Resistance to Antiestrogen Drugs
by: Svetlana E. Semina, et al.
Published: (2018-04-01)

Endometrial Metastasis from Breast Cancer during Adjuvant Endocrine Therapy
by: Fumikata Hara, et al.
Published: (2010-04-01)

Relationship between Chemotherapy and Tamoxifen with Incidence of Fatty Liver in Women with Breast Cancer
by: Sh Keyhanian, et al.
Published: (2013-08-01)

Spontaneous retrobulbar hemorrhage in a patient with breast cancer: A case report
by: Mohammad Taher Rajabi, et al.
Published: (2016-03-01)

Systematic development and validation of RP-HPLC method for simultaneous estimation of tamoxifen and sulphoraphane with specific application for nanolipidic formulations
by: Bharti Mangla, et al.
Published: (2020-11-01)

Younger tamoxifen-treated breast cancer patients also had higher risk of endometrial cancer and the risk could be reduced by sequenced aromatase inhibitor use: A population-based study in Taiwan
by: Sung-Chao Chu, et al.
Published: (2020-01-01)